180 Life Sciences Corp. - Common Stock (ATNF)
1.4000
-0.0400 (-2.78%)
180 Life Sciences Corp is a biotechnology company focused on developing innovative therapeutic solutions across a range of medical conditions, with an emphasis on chronic inflammatory diseases and pain management
The company leverages advanced scientific research to create and commercialize novel drug candidates, utilizing its expertise in cannabinoid therapy and other emerging treatment modalities. By addressing unmet medical needs, 180 Life Sciences aims to enhance patient outcomes and improve the quality of life for individuals suffering from debilitating conditions.
